RSS | Login | Register

Heart Disease

Treat complete heart risk

March 01, 2010

Tailoring treatment to individual heart attack risk was more effective in preventing heart attack, stroke, and cardiovascular death than strategies to lower cholesterol.

Statin approved for primary CVD prevention

February 09, 2010

FDA approval was based on the JUPITER study, which evaluated Crestor in a previously unstudied population.

Sleepiness linked to CVD mortality

June 05, 2009

Fibrate approved for use with a statin

May 07, 2009

Trilipix is used with diet to help lower triglycerides and LDL.

Must both atria be in fibrillation?

January 23, 2009

I have always assumed that atrial fibrillation means that both atria are in a quiver. Is it possible for only one atrium to be in fibrillation while the other is in a normal sinus rhythm, atrial flutter, atrial standstill, or other rhythm?

Aortic stenosis risk

January 22, 2009

Ezetimibe/simvastatin possibly associated with increased incidence of cancer

Brian S. Alper, MD, MSPH January 22, 2009

Ezetimibe/simvastatin (Vytorin) was associated with an increased incidence of cancer, based on a secondary analysis of the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) randomized trial.

What lipid levels lower atheroma burden?

January 08, 2009

PCPs show gender bias in CHD diagnoses

January 06, 2009

Women are less likely than men to be diagnosed with coronary heart disease if they mention a stressful event

Fibrate used in combination with statin approved

December 16, 2008

The FDA has approved Trilipix (fenofibric acid), a delayed-release capsule for use along with diet to treat dyslipidemia. Trilipix is the first fibrate to be approved for use in combination with a statin.

Kidney marker warns of heart disease risk

December 09, 2008

A new meta-analysis confirms "a strong and continuous association between proteinuria and subsequent risk of coronary heart disease."

Statins protect against CVD, not renal disease

December 04, 2008

Statin use does not decrease renal-function loss in patients without cardiovascular disease (CVD) or in those at risk for it, but the drug is effective for primary prevention of CVD, a study found.

Ambulatory BP betters office reads for CV risk

Delicia Yard November 25, 2008

A recent report found that office BP has no value in predicting cardiovascular (CV) morbidity and mortality in patients with resistant hypertension. Higher ambulatory measurements, however, are good indicators of these outcomes, according to the same report.

Stroke prevention with aspirin

November 10, 2008

The benefits of noninvasive coronary imaging

November 10, 2008

Scotoma relief following MI therapy

November 10, 2008

Lowering MI risk in patients with a high CRP

November 10, 2008

Combined BP regimen cuts death rates 40%

November 10, 2008

Supplementing diuretic hypertension therapy with a drug that conserves potassium sharply reduces fatal heart attacks and sudden cardiac death...

AHA suggests pre-stimulant ECG in children with ADHD

Brian S. Alper, MD, MSPH November 06, 2008

The American Heart Association (AHA) suggests a screening ECG before starting stimulant medications in children with attention-deficit hyperactivity disorder...

Thrombus aspiration during PCI reduces mortality and re-infarction

Brian S. Alper, MD, MSPH November 06, 2008

Thrombus aspiration during percutaneous coronary intervention (PCI) reduced mortality and re-infarction rate at one year...

Post-amiodarone paresthesias

November 03, 2008

Use aspirin in thrombocytopenic patients?

November 03, 2008

Updating the latest in hypertension therapy

Rod Richie, MD November 03, 2008

Most patients have no symptoms of hypertension until they suffer a major event. Here is a guide to help diagnose and manage this "silent killer."

Wolfberries

By Sherril Sego, MSN, FNP August 29, 2008

This unusually named berry is a staple in Chinese herbal medicine and is used for a multitude of health-boosting purposes. Also called goji berry, Chinese wolfberry, and Chinese boxthorn, it belongs to one of two closely...

Trial integrates depression and BP treatment

August 28, 2008

An integrated approach to hypertension and depression treatment yielded significantly better results for both conditions in a recent six-week pilot study. Patients in the integrated-care arm showed fewer...

Clot Prevention in a Patient with Drug Sensitivity

August 27, 2008

Would a large dose of vitamin E (1,600-2,400 IU) be an appropriate choice as a platelet inhibitor in a CAD patient who is allergic to aspirin, intolerant of...